Effectiveness across severe asthma biologic classes (Anti-IL-5 vs Anti IgE) in patients eligible for both (FIRE)

18/11/2020
23/04/2024
EU PAS number:
EUPAS38128
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

ISAR_OPCG1903_Effectiveness across Bx classes_Protocol 13 Aug 2020

English (351.33 KB - PDF) View document
Study results
No information provided.
Study report
No information provided.
ENCePP Seal
Conflicts of interest of investigators

200730_COI_David Price_V8

English (47.99 KB - PDF) View document
Composition of steering group and observers

Effectiveness Across Bx Classes_Steering Committee

English (11.46 KB - PDF) View document